Siegfried Holding AG
SFZN: XSWX (CHE)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|YS | LOCK|w^%hn | LOCK|KwVG?K< |
Siegfried: Management Focused on Expanding Global Manufacturing Capabilities; Shares Undervalued
During the second quarter, Siegfried inaugurated its new large-scale drug substance facility in Minden, Germany. It also completed its previously announced acquisition of two small-molecule sites in the US and one in Australia. Siegfried reports half-yearly, with financial results due in August.
